Literature DB >> 20167360

Balancing the benefits of statins versus a new risk-diabetes.

Christopher P Cannon1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2010        PMID： 20167360     DOI： 10.1016/S0140-6736(10)60234-6

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  6 in total

Review 1.  Clinician-patient risk discussion for atherosclerotic cardiovascular disease prevention: importance to implementation of the 2013 ACC/AHA Guidelines.

Authors:  Seth S Martin; Laurence S Sperling; Michael J Blaha; Peter W F Wilson; Ty J Gluckman; Roger S Blumenthal; Neil J Stone
Journal:  J Am Coll Cardiol       Date:  2015-04-07       Impact factor: 24.094

2.  Reexamining the declining effect of age on mortality differentials associated with excess body mass: evidence of cohort distortions in the United States.

Authors:  Yan Yu
Journal:  Am J Public Health       Date:  2011-11-28       Impact factor: 9.308

Review 3.  Lipid control in patients with diabetes mellitus.

Authors:  D John Betteridge
Journal:  Nat Rev Cardiol       Date:  2011-03-15       Impact factor: 32.419

Review 4.  A point-by-point response to recent arguments against the use of statins in primary prevention: this statement is endorsed by the American Society for Preventive Cardiology.

Authors:  Parag H Joshi; Sameer Chaudhari; Michael J Blaha; Steven R Jones; Seth S Martin; Wendy S Post; Christopher P Cannon; Gregg C Fonarow; Nathan D Wong; Ezra Amsterdam; John W Hirshfeld; Roger S Blumenthal
Journal:  Clin Cardiol       Date:  2012-06-06       Impact factor: 2.882

5.  Statins and risk of treated incident diabetes in a primary care population.

Authors:  Nur Lisa Zaharan; David Williams; Kathleen Bennett
Journal:  Br J Clin Pharmacol       Date:  2013-04       Impact factor: 4.335

6.  An integrative multiomic network model links lipid metabolism to glucose regulation in coronary artery disease.

Authors:  Ariella T Cohain; William T Barrington; Daniel M Jordan; Johan L M Bjorkegren; Eric E Schadt; Noam D Beckmann; Carmen A Argmann; Sander M Houten; Alexander W Charney; Raili Ermel; Katyayani Sukhavasi; Oscar Franzen; Simon Koplev; Carl Whatling; Gillian M Belbin; Jialiang Yang; Ke Hao; Eimear E Kenny; Zhidong Tu; Jun Zhu; Li-Ming Gan; Ron Do; Chiara Giannarelli; Jason C Kovacic; Arno Ruusalepp; Aldons J Lusis
Journal:  Nat Commun       Date:  2021-01-22       Impact factor: 14.919
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.